EUVIMEDEUVIMED entdecken
Crossref

Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice

Moe Tamaura, Naoko Satoh-Takayama, Miyuki Tsumura, Takaharu Sasaki, Satoshi Goda, Tomoko Kageyama, Seiichi Hayakawa, Shunsuke Kimura, Takaki Asano, Manabu Nakayama, Haruhiko Koseki, Osamu Ohara und 3 weitere

International Immunology · 12.04.2020 · 32 (4) · 259-272

DOI: 10.1093/intimm/dxz079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, online erschienen am 23.12.2019. Verfasst von Moe Tamaura und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Takeda Science Foundation, Mochida Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gain-of-function (GOF) mutations in the gene for signal transducer and activator of transcription 1 (STAT1) account for approximately one-half of patients with chronic mucocutaneous candidiasis (CMC) disease. Patients with GOF-STAT1 mutations display a broad variety of infectious and autoimmune manifestations in addition to CMC, and those with severe infections and/or autoimmunity have a poor prognosis. The establishment of safe and effective treatments based on a precise understanding of the molecular mechanisms of this disorder is required to improve patient care. To tackle this problem, we introduced the human R274Q GOF mutation into mice [GOF-Stat1 knock-in (GOF-Stat1R274Q)]. To investigate the immune responses, we focused on the small intestine (SI), which contains abundant Th17 cells. Stat1R274Q/R274Q mice showed excess phosphorylation of STAT1 in CD4+ T cells upon IFN-γ stimulation, consistent with the human phenotype in patients with the R274Q mutation. We identified two subpopulations of CD4+ T cells, those with ‘normal’ or ‘high’ level of basal STAT1 protein in Stat1R274Q/R274Q mice. Upon IFN-γ stimulation, the ‘normal’ level CD4+ T cells were more efficiently phosphorylated than those from WT mice, whereas the ‘high’ level CD4+ T cells were not, suggesting that the level of STAT1 protein does not directly correlate with the level of pSTAT1 in the SI. Inoculation of Stat1R274Q/R274Q mice with Candida albicans elicited decreased IL-17-producing CD4+RORγt+ cells. Stat1R274Q/R274Q mice also excreted larger amounts of C. albicans DNA in their feces than control mice. Under these conditions, there was up-regulation of T-bet in CD4+ T cells. GOF-Stat1R274Q mice thus should be a valuable model for functional analysis of this disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsCandida albicansGain of Function MutationHumansInterleukin-17MiceMice, Inbred C57BLSTAT1 Transcription FactorTh17 Cells

Stichwörter der Autor:innen

Th17 cellschronic mucocutaneous candidiasisinterleukin-17

Substanzen

IL17A protein, humanInterleukin-17STAT1 Transcription FactorSTAT1 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Department of Frontier Research and Development, Kazusa DNA Research Institute, Kisarazu, Japan.
  • Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Department of Applied Genomics, Kazusa DNA Research Institute, Kisarazu, Japan.
  • Laboratory for Integrative Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Takeda Science Foundation
  • Mochida Memorial Foundation
  • Japanese Society for Pediatric Endocrinology Future Development
  • Japanese Society of Hematology Research
  • Japan Agency for Medical Research and Development

Zitieren

APA

Tamaura, M., Satoh-Takayama, N., Tsumura, M., Sasaki, T., Goda, S., Kageyama, T., Hayakawa, S., Kimura, S., Asano, T., Nakayama, M., Koseki, H., Ohara, O., Okada, S., Ohno, H., & Kobayashi, M. (2020). Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice. International Immunology, 32(4), 259-272. https://doi.org/10.1093/intimm/dxz079

Vancouver

Tamaura M, Satoh-Takayama N, Tsumura M, Sasaki T, Goda S, Kageyama T, et al. Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice. International Immunology. 2020;32(4):259-272. doi:10.1093/intimm/dxz079

BibTeX
@article{Tamaura2020,
  author = {Tamaura, Moe and Satoh-Takayama, Naoko and Tsumura, Miyuki and Sasaki, Takaharu and Goda, Satoshi and Kageyama, Tomoko and Hayakawa, Seiichi and Kimura, Shunsuke and Asano, Takaki and Nakayama, Manabu and Koseki, Haruhiko and Ohara, Osamu and Okada, Satoshi and Ohno, Hiroshi and Kobayashi, Masao},
  title = {Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice},
  journal = {International Immunology},
  year = {2020},
  volume = {32},
  number = {4},
  pages = {259--272},
  doi = {10.1093/intimm/dxz079}
}
Kostenlos starten →